Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Snatched this off of reddit/cydy: (is there going

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 153821
(Total Views: 649)
Posted On: 05/13/2021 8:13:30 PM
Posted By: calstang
Re: Evil Rabbit #90093
Snatched this off of reddit/cydy: (is there going to be a trial in India?)

Nadar Says Macleods to Submit for EUA and Compassionate Use Authorization Immediately with India's CDSCO (their FDA)

Summary of Todays Proactive video on youtuve:


Macleods reached out to Cytodyn

Cytodyn and Macleods closed a deal in 10 days (they had a WhatsApp group text!)

Macleods will take Cytodyn's Leronlimab data and submit to CDSCO for EUA and Compassionate Use Authorization Immediately

Cytodyn is requesting the EUA (through Macleods) concurrently while they begin a patient trial in India:

the CDSCO granted this for Tocilizumab while they ran a 30 patient trial

Cytodyn is doing the above (request an EUA while conducting a trial) with every country that is in covid trouble

Dr Kelly feels for the first time they have a supportive Board of Directors...

Best financial position they've ever been in

We have a global distribution network

We have the crucial regulatory piece

Not only are physicians embracing Leronlimab, but international pharmaceutical companies are embracing Cytodyn

Companies in the Philippines, Brazil, India, the U.K. and now Europe, are looking at our data, our safety, our manufacturing and they're understanding the pipeline of opportunities ahead of us...

Leronlimab works at the CCR5 receptor, so it won't be affected by any mutations in the spike protein.

As more covid variants continue to emerge this will put us in a unique position

Macleod can not distribute LL to all hospitals in India, but all over the world (140 different countries)

Nader and Kelly both feel they now have a perfect team in place

They are working to start a HIV Prep trial in Brazil


(13)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us